BioScience Health Innovations (BHIC) Notes Payables (2021 - 2026)

BioScience Health Innovations (BHIC) reported Notes Payables of $460402.0 for Q1 2026, up 6430.52% quarter-over-quarter from $7050.0 in Q2 2022.

BioScience Health Innovations (BHIC) Notes Payables (2021 - 2026) Analysis & Trends

BioScience Health Innovations (BHIC) has 3 years of Notes Payables data on file, last reported at $460402.0 in Q1 2026.

  • Notes Payables for Q1 2026 came in at $460402.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $460402.0 (changed N/A YoY), and the FY2021 annual result was $7050.0, changed N/A from the prior year.
  • Notes Payables grew to $460402.0 in Q1 2026 per BHIC's latest filing, from $7050.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $460402.0 in Q1 2026 and troughed at $7050.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 High Tide 558.20 Mn 531.28 Mn 32.00 Mn
2 Wellgistics Health 385.01 Mn 384.95 Mn 170,221.00
3 Petmed Express 35.71 Mn 8.80 Mn 9.46 Mn
4 Scienture Holdings 14.72 Mn 14.72 Mn 53,850.00
5 Ridgetech 15.50 -4.11 Mn -
6 Scientist Home Future Health - - 32,589.00
7 BioScience Health Innovations - - 485,596.00
8 Rest Ez - - -
9 Polomar Health Services - - 550,489.00

Historic Data

Download Data
DateValue
Mar 31, 2026 460,402.00
May 31, 2022 7,050.00
Feb 28, 2022 7,050.00
Nov 30, 2021 7,050.00
Aug 31, 2021 7,050.00